Please feel free to forward to fellow researchers and share news of our journal | Dear Colleague, We are delighted to announce the publication of Volume 6, Issue 1 of our Kidney Cancer journal. This issue includes a review on cytoreductive nephrectomy in advanced renal cancer, plus one research article, three systematic reviews, and a case report, along with an obituary for Chris Wood. From the editor of our regular journal section, there is also a new Clinical Trials Corner contribution. View all the open access content via the links below. We also share news of the journal supporting IOS Press' actions relating to the UN sustainable development goals (SDGs). | Call for Papers As a member of our community, we would like to invite you to submit your own research articles to the journal, which offers contributing authors many benefits: • First class Editorial Board
• Rigorous peer review and speedy manuscript processing
• Rapid online publication (pre-press) on acceptance
• The first volumes of the journal freely available to all readers
• Articles accepted this year will be published open access with no article processing fee Submit your manuscript online via Editorial Manager
View detailed Instructions to Authors
Aims and Scope Kidney Cancer is an international, multidisciplinary journal that provides an invaluable and indispensable platform for the many collaborative, transdisciplinary, and translational efforts to help treat and finally cure this malignancy. Best wishes, Primo N. Lara Jr, MD
UC Davis Comprehensive Cancer Center
Sacramento, CA, USA
Email: kca@iospress.com Peter Mulders, MD, PhD
Radboud UMC
Nijmegen, The Netherlands
Email: kca@iospress.com Editors-in-Chief
Sign up now for Kidney Cancer news
Join the conversation at: twitter.com/KCA_Journal | All articles are freely available online for all to read, download and share. Obituary
In Memoriam: Chris Wood – Openly Available
Lara Jr, Primo N. | Mulders, Peter Review Article
“PROBE”ing the Role of Cytoreductive Nephrectomy in Advanced Renal Cancer – Open Access
Bell, Hannah | Cotta, Brittney H. | Salami, Simpa S. | Kim, Hyung | Vaishampayan, Ulka RESEARCH ARTICLE
Patient-Derived Renal Cell Carcinoma Xenografts Capture Tumor Genetic Profiles and Aggressive Behaviors – Open Access
Beserra, Adriano O. | Estevan, Ethiene C. | Bezerra, Stephania M. | Torrezan, Giovana T. | Ikegami, Amanda | Dellê, Humberto | Cunha, Isabela W. | Meira, Isabella T. | Carraro, Dirce M. | Lara Jr., Primo N. | Zequi, Stenio C. | Martins, Vilma R. | Santos, Tiago G. Systematic Reviews
BRCA1-Associated Protein 1 (BAP-1) as a Prognostic and Predictive Biomarker in Clear Cell Renal Cell Carcinoma: A Systematic Review – Open Access
Gulati, Shuchi | Previtera, Melissa | Lara Jr., Primo N. Comparative Evaluation of Safety and Efficacy of Alternate Schedule (AS) of Sunitinib in Asian and Non-Asian Patient Population for the Treatment of Metastatic Renal Cell Cancer (mRCC): A Meta-Analysis – Open Access
Joshi, Amit | Patel, Ishan | Kapse, Pratiksha | Singh, Manmohan Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma – Openly Available
Brown, Jason R. | Calaway, Adam | Castle, Erik | Garcia, Jorge | Barata, Pedro C. Case Report
Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma – Open Access
Sharma, Akanksha | Elias, Roy | Christie, Alana | Williams, Noelle S. | Pedrosa, Ivan | Bjarnason, Georg A. | Brugarolas, James CLINICAL TRIALS CORNER
Clinical Trials Corner: Nephrectomy in the New Year – Open Access
Parikh, Mamta | Most Viewed Kidney Cancer Articles in Q1 2022 Listing articles published in 2021 and 2022 so you can read the most popular recent content Phase Ib/II trial of Ibrutinib and Nivolumab in Patients with Advanced Refractory Renal Cell Carcinoma (Research Article in Vol.5, Iss.4, 2021) – Open Access
Parikh, Mamta | Tenold, Matthew E. | Qi, Lihong | Lara, Frances | Robles, Daniel | Meyers, Frederick J. | Lara, Primo N. Sarcomatoid Renal Cell Carcinoma: The Present and Future of Treatment Paradigms (Review Article in Vol.5, Iss.4, 2021) – Open Access
Candelario, Nellowe | Geiger, Christopher | Flaig, Thomas Adjuvant Therapy in Renal Cell Carcinoma: Current Status and Future Directions (Review Article n Vol.5, Iss.1, 2021) – Open Access
Kazarian, Austin G. | Chawla, Neal S. | Muddasani, Ramya | Pal, Sumanta K. First-Line Immuno-Oncology Combinations for Metastatic Clear Cell Renal Cell Carcinoma (mRCC): A Systematic Review of Phase III Clinical Trials (Systematic Review in Vol.5, Iss.4, 2021) – Open Access
Hahn, Andrew W. | Shah, Amishi Y. | Campbell, Matthew T. Retrospective Study of Real-World Treatment Patterns and Outcomes in Advanced/Metastatic Renal Cell Carcinoma Patients Receiving Lenvatinib/Everolimus after Heavy Pretreatment (Research Article in Vol.5, Iss.4, 2021) – Open Access
Vogelzang, Nicholas J. | Monnette, Alisha M. | Wang, Yunfei | Wan, Yin | Robert, Nicholas J. | Tannir, Nizar M. Extended Disease Control with Unconventional Cabozantinib Dose Increase in Metastatic Renal Cell Carcinoma (Case Report in Vol.6, Iss.1, 2022) – Open Access
Sharma, Akanksha | Elias, Roy | Christie, Alana | Williams, Noelle S. | Pedrosa, Ivan | Bjarnason, Georg A. | Brugarolas, James | Kidney Cancer Association News Antwerp, Belgium | April 22–24, 2022 The International Kidney Cancer Symposium: Europe is an important meeting held each spring by the Kidney Cancer Association. This it is back as an in-person event and will be an opportunity for physicians, researchers, academics, and industry professionals from across the globe to join together and exchange ideas which will direct the future of kidney cancer research and treatment in the ultimate pursuit of a cure. The 2022 event takes place in Antwerp, Belgium over the course of three days, April 22–24. Registration is open and you can find details by clicking the banner below! | View the full EIKCS 2022 program via the website here | Kidney Cancer Journal News Supporting the IOS Press Diversity and Inclusion Statement IOS Press is a signatory of the UN SDG Publishers Compact and is taking actions relating to specific sustainable development goals (SDGs). This includes working with journal editors to share recommendations in relation to SDG 5 (gender equality) and SDG 10 (reducing inequalities) in terms of diversity. We are pleased to announce that our journal supports the IOS Press Diversity and Inclusion Statement and is committed to take action to improve geographical and gender equality for the journal. Any updates will be shared on the IOS Press journal page in due course. | Please Share Kidney Cancer News With Your Colleagues Help Spread the News! | If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the visual or access the sign-up link here. Kidney Cancer has an active social media presence. If you are not yet interacting with the journal on social media, why not take the time today to follow us on Twitter? Be part of the discussion! | You are receiving this mailing as you are signed up to receive news from us.
You can unsubscibe or alter your preferences at any time by clicking the links below. | |
